Calcilytix Therapeutics, Inc., A Bridgebio Company

This study is testing a drug called encaleret in children from birth to age 17 who have a rare inherited condition called Autosomal Dominant Hypocalcemia Type 1 (ADH1). ADH1 causes low blood calcium and related health problems. The main goals are to see how the child's body proce…